Inhibitor Therapeutics, Inc. (INTI)

USD 0.06

(20.0%)

Gross Profit Summary of Inhibitor Therapeutics, Inc.

  • Inhibitor Therapeutics, Inc.'s latest annual gross profit in 2023 was - USD , down 0.0% from previous year.
  • Inhibitor Therapeutics, Inc.'s latest quarterly gross profit in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Inhibitor Therapeutics, Inc. reported a annual gross profit of - USD in annual gross profit 2022, down 0.0% from previous year.
  • Inhibitor Therapeutics, Inc. reported a annual gross profit of - USD in annual gross profit 2021, down 0.0% from previous year.
  • Inhibitor Therapeutics, Inc. reported a quarterly gross profit of - USD for 2024 Q1, down 0.0% from previous quarter.
  • Inhibitor Therapeutics, Inc. reported a quarterly gross profit of - USD for 2023 Q1, down 0.0% from previous quarter.

Annual Gross Profit Chart of Inhibitor Therapeutics, Inc. (2023 - 1996)

Historical Annual Gross Profit of Inhibitor Therapeutics, Inc. (2023 - 1996)

Year Gross Profit Gross Profit Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 100.0%
2014 -26.49 Thousand USD 0.0%
2013 - USD 100.0%
2012 -560.67 Thousand USD 0.0%
2011 - USD -100.0%
2010 610.28 Thousand USD -39.63%
2009 1.01 Million USD -54.29%
2008 2.21 Million USD 23.07%
2007 1.79 Million USD 64.3%
2006 1.09 Million USD -52.63%
2005 2.3 Million USD 16.6%
2004 1.98 Million USD 25.7%
2003 1.57 Million USD 37.65%
2002 1.14 Million USD 24.93%
2001 916.18 Thousand USD -60.47%
2000 2.31 Million USD 61.31%
1999 1.43 Million USD 79.58%
1998 800 Thousand USD -38.46%
1997 1.3 Million USD 44.44%
1996 900 Thousand USD 0.0%

Peer Gross Profit Comparison of Inhibitor Therapeutics, Inc.

Name Gross Profit Gross Profit Difference
Burzynski Research Institute, Inc. - USD NaN%
Arch Therapeutics, Inc. -2439.00 USD 100.0%
Evofem Biosciences, Inc. 11.7 Million USD 100.0%
Nascent Biotech, Inc. -319.5 Thousand USD 100.0%
Rebus Holdings, Inc. - USD NaN%
Santhera Pharmaceuticals Holding AG 119.1 Million USD 100.0%
Qrons Inc. - USD NaN%
Adynxx, Inc. - USD NaN%
Neon Bloom, Inc. - USD NaN%
Northwest Biotherapeutics, Inc. -25.79 Million USD 100.0%
ProtoKinetix, Incorporated -48.25 Thousand USD 100.0%
Skye Bioscience, Inc. -124.25 Thousand USD 100.0%
Eiger BioPharmaceuticals, Inc. 14.99 Million USD 100.0%
Nanobac Pharmaceuticals, Incorporated 3102.00 USD 100.0%
Institute of Biomedical Research Corp. - USD NaN%
SQZ Biotechnologies Company 9.79 Million USD 100.0%
Intellipharmaceutics International Inc. 65.72 Thousand USD 100.0%
Propanc Biopharma, Inc. -34.15 Thousand USD 100.0%
Mesoblast Limited -35.16 Million USD 100.0%
Marizyme, Inc. 457.7 Thousand USD 100.0%
Genus plc 178.7 Million USD 100.0%
VioQuest Pharmaceuticals, Inc. - USD NaN%
Pharming Group N.V. 220.1 Million USD 100.0%
Therapeutic Solutions International, Inc. 62.22 Thousand USD 100.0%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD 100.0%
Nymox Pharmaceutical Corporation -11 Thousand USD 100.0%
ContraFect Corporation -154 Thousand USD 100.0%
PsyBio Therapeutics Corp. -50 Thousand USD 100.0%
Sienna Biopharmaceuticals, Inc. - USD NaN%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD 100.0%
IMV Inc. -962.29 Thousand USD 100.0%
AXIM Biotechnologies, Inc. -387.5 Thousand USD 100.0%
MultiCell Technologies, Inc. 49.32 USD 100.0%
ONE Bio Corp. 20.12 Million USD 100.0%
Accustem Sciences Inc. - USD NaN%
RVL Pharmaceuticals plc 40.26 Million USD 100.0%
Arno Therapeutics, Inc. - USD NaN%
EV Biologics, Inc. 48.9 Thousand USD 100.0%
Q BioMed Inc. -8988.00 USD 100.0%
Emmaus Life Sciences, Inc. 28.25 Million USD 100.0%
Mosaic ImmunoEngineering Inc. - USD NaN%
Biomind Labs Inc. -15.42 Thousand USD 100.0%
American Oriental Bioengineering, Inc. 44.35 Million USD 100.0%
Provectus Biopharmaceuticals, Inc. -1.14 Million USD 100.0%
TetraLogic Pharmaceuticals Corporation - USD NaN%
Oncotelic Therapeutics, Inc. 70 Thousand USD 100.0%
GlobeStar Therapeutics Corporation - USD NaN%
THC Farmaceuticals, Inc. -4952.00 USD 100.0%
Acro Biomedical Co., Ltd. 140.5 Thousand USD 100.0%
Curative Biotechnology, Inc. -97.51 Thousand USD 100.0%
GB Sciences, Inc. -624.00 USD 100.0%
Alpha Cognition Inc. -86.02 Thousand USD 100.0%
HST Global, Inc. - USD NaN%
CSL Limited 7.56 Billion USD 100.0%
Wesana Health Holdings Inc. - USD NaN%
Halberd Corporation -208.00 USD 100.0%
Enzolytics Inc. 30.7 Thousand USD 100.0%
Agentix Corp. - USD NaN%
Resverlogix Corp. - USD NaN%
Nuo Therapeutics, Inc. 482.43 Thousand USD 100.0%
MetaStat, Inc. - USD NaN%
argenx SE 1.1 Billion USD 100.0%
Enzon Pharmaceuticals, Inc. - USD NaN%
Endonovo Therapeutics, Inc. -514.51 Thousand USD 100.0%
RespireRx Pharmaceuticals Inc. - USD NaN%
GeneThera, Inc. - USD NaN%
AVAX Technologies, Inc. 617.38 Thousand USD 100.0%
Zenith Capital Corp. - USD NaN%
Genscript Biotech Corporation 409.55 Million USD 100.0%
Ember Therapeutics, Inc. - USD NaN%
Anthera Pharmaceuticals, Inc. - USD NaN%
Sigyn Therapeutics, Inc. -8856.00 USD 100.0%
WPD Pharmaceuticals Inc. - USD NaN%
Cotinga Pharmaceuticals Inc. -83.84 Thousand USD 100.0%
Kadimastem Ltd -630.13 Thousand USD 100.0%
Helix BioMedix, Inc. 987.98 Thousand USD 100.0%
VitaSpring Biomedical Co. Ltd. - USD NaN%
Capstone Therapeutics Corp. 9.61 Million USD 100.0%
BioStem Technologies, Inc. 15.42 Million USD 100.0%
Oncology Pharma Inc. - USD NaN%
Reve Technologies, Inc. - USD NaN%
LadRx Corporation -11.83 Thousand USD 100.0%
Cell Source, Inc. - USD NaN%
Regen BioPharma, Inc. 176.56 Thousand USD 100.0%
Regen BioPharma, Inc. 176.56 Thousand USD 100.0%
NovAccess Global Inc. - USD NaN%
Affymax, Inc. 1.35 Million USD 100.0%
Itoco Inc. - USD NaN%
Rasna Therapeutics, Inc. - USD NaN%
Pathfinder Cell Therapy, Inc. - USD NaN%
Mobile Lads Corp. - USD NaN%
CytoDyn Inc. -29 Thousand USD 100.0%
Claritas Pharmaceuticals, Inc. - USD NaN%
NDT Pharmaceuticals Inc. - USD NaN%
NanoSphere Health Sciences Inc. - USD NaN%
Alseres Pharmaceuticals, Inc. 450.04 Thousand USD 100.0%
SYBLEU INC 11.69 Thousand USD 100.0%
Advanced Proteome Therapeutics Corporation - USD NaN%
ImmunoCellular Therapeutics, Ltd. - USD NaN%
International Stem Cell Corporation 4.6 Million USD 100.0%
Bioxytran, Inc. -8285.00 USD 100.0%
GlobeImmune, Inc. - USD NaN%
Predictive Technology Group, Inc. - USD NaN%
ProText Mobility, Inc. - USD NaN%
Cardax, Inc. - USD NaN%
VG Life Sciences Inc. - USD NaN%
Kaleido Biosciences, Inc. - USD NaN%
Advaxis, Inc. - USD NaN%
Adhera Therapeutics, Inc. - USD NaN%
RenovaCare, Inc. - USD NaN%
Regnum Corp. - USD NaN%
Innovation Pharmaceuticals Inc. -373 Thousand USD 100.0%
Neutra Corp. 14.33 Thousand USD 100.0%
Windtree Therapeutics, Inc. -82 Thousand USD 100.0%
PureTech Health plc -1.6 Million USD 100.0%
Coeptis Therapeutics, Inc. -1 Million USD 100.0%
IXICO plc 3.27 Million USD 100.0%
IntelGenx Technologies Corp. -694 Thousand USD 100.0%
Gelesis Holdings, Inc. -1.79 Million USD 100.0%
CSL Limited 7.7 Billion USD 100.0%
Cellectis S.A. 18 Thousand USD 100.0%